Our Team
Pixel Wiser’s core team members come from leading global life science solution providers, bringing deep academic expertise, extensive project experience, and a strong client reputation. The team has successfully supported drug approvals with major regulatory worldwide, including the FDA, EMA, NMPA and PMDA. Serving over 60 clients, Pixel Wiser works with global top-tier pharma companies, established Chinese pharma firms, and emerging biotech companies.
Project Management team has more than 10 years’ experience in BICR. All Imaging Management Team members have medical imaging background. All Medical Team members are Experienced Radiologists. The Software Team has deep healthcare industry expertise and participated in multiple GCP/GLP compliant platforms development and validation.
50+ More than 50 inspection and drug approval records in global regulatory including FDA (USA), EMA (EU), NMPA (China) and PMDA (Japan).
Expertise in over 200 BIRC projects for clinical trials, spanning diverse oncology indications and therapeutic classes, including immunotherapeutic antibodies, targeted small-molecule, Cell & Gene Therapies, and XDC interventions. Focus encompasses patient populations across early-stage tumor, first/second-line systemic therapies, and adjuvant/neoadjuvant treatment paradigms.
Founded in 2022.
Pixel Wiser is an Independent Review Committee service provider (IRC) established by an experienced industry team.
Pixel Wiser
Follow Us
Find more about Medical Imaging